Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C16orf86 (Chromosome 16 open reading frame 86) encodes a protein of unknown function in humans. It is annotated as a protein-coding gene, but as of now, no molecular function, mechanism of action, or protein class assignment is established. C16orf86 has not been characterized as a receptor, enzyme, transporter, or any standard molecular target type. Current evidence is limited to gene expression data suggesting its possible inclusion in multi-gene transcriptomic panels for cancer prognosis, particularly in pancreatic adenocarcinoma, but it is not known to have direct disease roles or therapeutic relevance. There are no reported drug interactions, no functional domains, and no described mechanisms of action[1][2][3][5]. In summary: C16orf86 is a protein-coding gene with unclear biological and disease relevance, lacking evidence as a therapeutic target, and currently classified as an “uncharacterized protein.”
None (No mechanisms of action are described due to lack of drugs targeting C16orf86)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 16 open reading frame 86 (C16orf86).